Investors

Almirall's Financial Calendar for 2013

Barcelona, January, 23rd 2013.- Almirall announced today its financial calendar for 2013:

25 February 2013: Full year 2012 results

7 May 2013: First Quarter 2013 results

29 July 2013: First Half 2013 results

11 November 2013: Third Quarter 2013 results

Almirall Almirall is a pharmaceutical company committed to innovate through valuable medicines. Headquartered in Barcelona, Spain, it researches, develops, manufactures and commercializes its own R&D and licensed drugs with the aim of improving people's health and wellbeing now and to future generations. Almirall medicines, focused on respiratory, dermatology, gastrointestinal and pain, are currently in over 70 countries while the company has direct presence in Europe, Mexico and Canada through 13 affiliates.

For more information, visit: www.almirall.com

Media information: Investor Relations enquiries:
Ketchum Almirall
Sonia San Segundo Jordi Molina
sonia.sansegundo@ketchum.com jordi.molina@almirall.com
Tel.: 00 34 91 788 32 00 Tel.: 00 34 93 291 30 87

Press release